⚡ Flash Summary
AGIC is issuing right shares, with the book closure for determining eligibility set from November 6th to November 6th, 2025. The credit of unpaid rights into CDC in book entry form will occur on November 7th, 2025, and offer letters will be dispatched to physical shareholders on November 11th, 2025. Trading of unpaid rights on the Pakistan Stock Exchange Ltd will commence on November 10th, 2025. The last date for acceptance and payment for shares is December 1st, 2025, and the allotment of shares and credit of book entry into CDC is scheduled for December 15th, 2025.
📌 Key Takeaways
- 📅 Book closure for right issue eligibility: November 6th, 2025.
- 🏦 Credit of unpaid rights into CDC: November 7th, 2025.
- ✉️ Dispatch of offer letters to physical shareholders: November 11th, 2025.
- 📢 Intimation to Stock Exchange for dispatch: November 11th, 2025.
- 📈 Commencement of trading of unpaid rights: November 10th, 2025.
- ✂️ Last date for splitting and deposit of Requests into CDS: November 13th, 2025.
- 🤝 Last date of trading of Rights Letters: November 24th, 2025.
- ✅ Last date for acceptance and payment: December 1st, 2025.
- 分配 Allotment of shares and credit into CDC: December 15th, 2025.
- 📦 Dispatch of physical share certificates: December 15th, 2025.
- 📜 Compliance with Companies Act 2017 and related regulations is mandatory.
- 📑 Submission of cancelled Offer Letter and Schedule 1 to the Exchange is required.
- 🔄 Revised free-float details to be submitted post right issue.
🎯 Investment Thesis
Based on the current information, a HOLD recommendation is appropriate. The right issue presents both opportunities and risks. While it can strengthen the company’s capital base, it also dilutes existing shareholders. Further information on the specific terms of the right issue (e.g., issue price, ratio) and the company’s intended use of funds would be necessary to make a more definitive recommendation. The price target cannot be determined until further information is released. More information regarding the funds use is needed.
Disclaimer: AI-generated analysis. Not financial advice.